CHICAGO, July 16,
2024 /PRNewswire/ -- Bloomage, a global leader
specializing in hyaluronic acid and other bioactive substance
innovations, launched its new product - MitoPQQ™ and presented its
latest hyaluronic acid research at the 2024 IFT FIRST expo, one of
the largest gatherings of global experts in the food science
industry. Focused on skin beauty,emotional & sleep health,
joint health, cognitive health, gastrointestinal protection, eye
health and energy boost, Bloomage's bioactive innovations gained
widespread interest at the event.
New product launch: Bloomage MitoPQQ™
As interest in the anti-aging trend rises among consumers, the
market is set to grow rapidly. According to Grand View Research,
the global anti-aging products market is expected to grow at a CAGR
of 5.4% from 2021 to 2028. Furthermore, Transparency Market
Research highlighted that North
America is a key market for this sector, driven by
increasing awareness, research, and technological advancement. This
sets up an emerging opportunity for anti-aging functional food
manufacturers.
Metabolism gradually decreases with age, leading to less
efficient breakdown of nutrients and lower energy production. To
alleviate aging caused by declining metabolism, Bloomage launched
water-soluble MitoPQQ™ that's naturally found in a variety of
fruits, vegetables, and grains. This breakthrough innovation
accelerate the transformation of longevity factor -NAD+, and
promote the efficient operation of mitochondria, a critical
coenzyme for cellular metabolism. It also combats cellular and skin
aging, enhances cognitive function, boosts energy, enhancing the
capabilities of functional foods as an additive.
Featuring Bloomage's quality, reliability, and safety, MitoPQQ™
is produced using fermentation process with food-grade substances.
It's non-GMO, non-toxic, and free of harmful byproducts. With
stringent quality control, Bloomage ensures high purity and high
stability. The product is also certified for GRAS, KOSHER, HALAL,
HACCP, and FSMA in the United
States.
Presenting the latest research on oral hyaluronic
acid
Bloomage also presented its research on how oral hyaluronic acid
promotes joint and gastrointestinal health at the IFT FIRST expo.
The company also showcased its UltraHA® J, a hyaluronic
acid product designed to support joint health, and its
UltraHA®-GI-001 hyaluronic acid product for gut
health.
"Hyaluronic acid's health benefits have been recognized globally
for many years, with its effectiveness as a functional food
ingredient confirmed by numerous studies," said Dr. Hai Ning Shi, Chief Scientist of Bloomage Health
Food Center.
As the major component of synovial fluid, it plays a protective
role in shock absorption and lubrication. Additionally, it helps
maintain the health of cartilage. As the hyaluronic acid level
naturally declines with age, it can lead to joint pain and
complications in mobility. To counter this, Bloomage has developed
the UltraHA® J sodium hyaluronate specifically
formulated to promote joint health. In clinical trials,
UltraHA® J has been shown to alleviate joint
discomfort.
In 2018, Bloomage partnered with Harvard
Medical School to study hyaluronic acid's impact on gut
health. After four years, their research confirmed that oral
hyaluronic acid reduces gut inflammation, promotes beneficial gut
bacteria growth, and regulates the intestinal barrier. The paper
was published in the Gut Microbes journal. This study set
the foundation for the development of
UltraHA®-GI-001.
Investing in health food innovation
Bloomage continuously invests in advanced technology to increase
its commitment to its customers. In June
2024, Bloomage announced that it would invest a total
of 1 billion RMB (~138 million USD)
in a new state-of-the-art health food headquarters. Designed to
integrate research, production, and sales into a single site, the
21,500 square meter facility and its nine production lines will
develop and produce various forms of food materials.
Food grade raw materials are a critical part of Bloomage's wide
range of bioactive substance solutions portfolio. Its
Nutrition&Health Raw Materials Business Division aims to
enhance, innovate, and upgrade functional food ingredients to meet
evolving consumer demands with cutting-edge solutions.
About Bloomage
In 2000, Bloomage took its first steps as a producer of
hyaluronic acid using microbial fermentation. After more than 20
years, Bloomage has emerged as a leading global bioacitive
substance company. Additionally, Bloomage is contributing to the
growth of the nutritional supplement industry with new bioactive
compound research created through its advanced fermentation and
foundational research. Bloomage is dedicated to improving people's
quality of life by creating healthier experiences.
Media Contact
Cecilia Qian
Cecilia@ecoinst.ca
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bloomage-launches-mitopqq-and-presents-hyaluronic-acid-research-at-ift-first-expo-2024-302197928.html
SOURCE Bloomage